Clinical Trial Results:
A randomised, double-blind, double-dummy, parallel-group multicenter study to demonstrate improvement in symptoms of constipation in subjects with non-malignant pain taking oxycodone equivalent of 60 - 80 mg/day as oxycodone / naloxone prolonged release (OXN) compared to subjects taking oxycodone prolonged release tablets alone.
Summary
|
|
EudraCT number |
2005-003510-15 |
Trial protocol |
FI DE GB ES CZ HU |
Global completion date |
12 Jul 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2 |
This version publication date |
04 Mar 2016
|
First version publication date |
07 May 2015
|
Other versions |
v1 , v3 , v4 |
Version creation reason |
|
Summary report(s) |
OXN3006 CSR Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.